Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
Nadda chairs Joint Strategy Meeting with Line Ministries for TB Mukt Bharat Abhiyan- 100-Day Intensified Campaign
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Subscribe To Our Newsletter & Stay Updated
